Description

Ferrone et al identified risk factors associated with survival in a patient with a resectable pancreatic adenocarcinoma. These can help identify a patient who may benefit from more aggressive or novel therapies. The authors are from Memorial Sloan-Kettering Cancer Center in New York and Massachusetts General Hospital in Boston.


 

Patient selection: resectable pancreatic adenocarcinoma (T1 to T3 and M0)

 

Parameters identified on multivariate analysis:

(1) change in the serum CA19-9 concentration before and after surgery

(2) serum concentration of CA19-9 after surgery

(3) T stage

(4) N stage (presence or absence of lymph node metastases)

Parameter

Finding

Points

change in serum CA19-9

postoperative decrease or no change

0

 

postoperative increase

1

postoperative CA19-9 level

<= 200 U/mL (<= 5.4 times ULN)

0

 

> 200 U/mL (> 5.4 times ULN)

1

T stage

T1 or T2

0

 

T3

1

lymph node metastases

absent (N0)

0

 

present (N1)

1

 

where:

• The upper limit of the normal reference range for serum CA19-9 was 37 U/mL.

• The odds ratios for the risk factors ranged from 2.5 to 3.2.

 

number of risk factors associated with increased mortality =

= SUM(points for all 4 parameters)

 

Interpretation:

• minimum score: 0

• maximum score: 4

• The higher the score the worse the survival.

 


To read more or access our algorithms and calculators, please log in or register.